Journal article
5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy
- Abstract:
-
The tumour-associated antigen 5T4 is an attractive target for cancer immunotherapy. However to date, reported 5T4-specific cellular immune responses induced by various immunisation platforms have been largely weak or non-existent. In the present study, we have evaluated a heterologous prime boost regime based on the simian adenovirus ChAdOx1 and modified vaccinia virus Ankara (MVA) expressing 5T4 for immunogenicity and tumour protective efficacy in a mouse cancer model. Vaccination-induced im...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
Actions
Access Document
- Files:
-
-
(pdf, 2.4MB)
-
- Publisher copy:
- 10.18632/oncotarget.17666
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
+ National Institutes for Health Research
More from this funder
Grant:
Oxford Biomedical Research Centre, UK (IR)
+ European Union
More from this funder
Grant:
Seventh Framework Programme under grant agreement No. 602705 ( (FC, EP).
Bibliographic Details
- Publisher:
- Impact Journals Publisher's website
- Journal:
- Oncotarget Journal website
- Volume:
- 8
- Issue:
- 29
- Pages:
- 47474-47489
- Publication date:
- 2017-05-07
- DOI:
- ISSN:
-
1949-2553
- Pubs id:
-
pubs:698059
- URN:
-
uri:0a97069a-13de-4276-bef3-0adc8e6b4cc3
- UUID:
-
uuid:0a97069a-13de-4276-bef3-0adc8e6b4cc3
- Local pid:
- pubs:698059
- Paper number:
- 29
Item Description
- Language:
- English
- Keywords:
Terms of use
- Copyright holder:
- Cappuccini et al.
- Copyright date:
- 2017
- Notes:
-
Copyright © Cappuccini et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC-BY),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
If you are the owner of this record, you can report an update to it here: Report update to this record